Neurizon inks $1.5M loan against R&D Tax Rebate
Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SEA | duster-a definition for holders | 19/01/25 | 1 | 1.9K | |||
|
|||||||
SEA | asx - bhp comments | 04/07/22 | 1 | 1.5K | |||
|
|||||||
SEA | AGM Presentation 2020 | 05/02/22 | 100 | 45K | |||
|
|||||||
SEA | Lonestar Restructuring | 16/09/20 | 2 | 2.6K | |||
|
|||||||
SEA | SNDE 2019 10K (Annual Report) Released | 25/07/20 | 306 | 57K | |||
|
|||||||
SEA | Share Sale Facility | 23/07/20 | 2 | 1.8K | |||
|
|||||||
SEA | What happened? | 25/06/20 | 8 | 6.3K | |||
|
|||||||
SEA | SNDE information for investors that stick around | 31/05/20 | 372 | 182K | |||
|
See All Discussions